Literature DB >> 2492748

Failure of once-daily penicillin V therapy for streptococcal pharyngitis.

M A Gerber1, M F Randolph, K DeMeo, H M Feder, E L Kaplan.   

Abstract

To determine if a single daily dose of penicillin V would be effective in the treatment of group A beta-hemolytic streptococcal (GABHS) pharyngitis, 154 patients with GABHS pharyngitis were randomly assigned to receive 750 mg of penicillin V once daily for ten days or 250 mg of penicillin V three times daily for ten days. The two regimens were comparable in their ability to eradicate GABHS from the upper respiratory tract in 18 to 24 hours and in their impact on the clinical course of the disease. However, a bacteriologic treatment failure occurred in six (8%) of the 76 patients in the three-times-daily group and in 16 (22%) of the 74 patients in the once-daily group. These findings support the current recommendation that penicillin V be given in two or more divided doses for a full ten days for the treatment of GABHS pharyngitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492748     DOI: 10.1001/archpedi.1989.02150140039016

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  11 in total

1.  Epidemiology and pharmacoeconomic issues relating to acute respiratory tract infections and acute uncomplicated infections of the urinary tract.

Authors:  N M Graham
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

2.  Molecular DNA analysis for differentiation of persistence or relapse from recurrence in treatment failure of Streptococcus pyogenes pharyngitis.

Authors:  F Fitoussi; R Cohen; G Brami; C Doit; N Brahimi; F de la Rocque; E Bingen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-03       Impact factor: 3.267

Review 3.  Rational prescribing of antibacterials in ambulatory children.

Authors:  J E Hoppe
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

4.  Streptococcus pyogenes pharyngitis: characterization of strains by multilocus enzyme genotype, M and T protein serotype, and pyrogenic exotoxin gene probing.

Authors:  J M Musser; B M Gray; P M Schlievert; M E Pichichero
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

Review 5.  Antibiotics for treatment of sore throat in children and adults.

Authors:  Anneliese Spinks; Paul P Glasziou; Chris B Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2021-12-09

6.  Treatment of streptococcal pharyngitis with amoxycillin once a day.

Authors:  P Shvartzman; H Tabenkin; A Rosentzwaig; F Dolginov
Journal:  BMJ       Date:  1993-05-01

7.  Randomized evaluation of benzathine penicillin V twice daily versus potassium penicillin V three times daily in the treatment of group A streptococcal pharyngitis. Pharyngitis Study Group.

Authors:  A Kaufhold
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

Review 8.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 9.  Treatment Challenges of Group A Beta-hemolytic Streptococcal Pharyngo-Tonsillitis.

Authors:  Itzhak Brook
Journal:  Int Arch Otorhinolaryngol       Date:  2016-06-03

Review 10.  Antibiotics for sore throat.

Authors:  Anneliese Spinks; Paul P Glasziou; Chris B Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2013-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.